Published in Cancer Weekly, August 7th, 2007
"By using 5' deletion constructs of MMP-2 promoter, we demonstrated that binding sites for p53, S1, AP-1...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.